Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV‐Infected Patients
Dario Cattaneo(ASST Fatebenefratelli Sacco), Emilio Clementi(Luigi Sacco Hospital), Sara Baldelli(Luigi Sacco Hospital), Valeria Cozzi(Luigi Sacco Hospital), Serena Fucile(Luigi Sacco Hospital), Cristina Gervasoni(University of Padua), Paola Meraviglia(Luigi Sacco Hospital), Diego Ripamonti(Ospedale Papa Giovanni XXIII), Simona Landonio(ASST Fatebenefratelli Sacco)
Cited by 19
Related Papers
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|589
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
|Proceedings of the National Academy of Sciences|2004|496
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
|Cell Death and Disease|2012|265
Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV
|HIV Medicine|2020|166
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133